Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

🔷 This comprehensive update incorporates the latest evidence published since the previous guideline, with changes that may have a meaningful impact on clinical practice.

🔗 Read more: bit.ly/ONCOnews04Fe...

#ONCOnews #OncoAlert #OncEd #ASCOGuidelines #LivingGuideline #NSCLC #NonSmallCellLungCancer

🔷 Since the 2024 update, the guideline incorporates seven new regulatory approvals and changes in first-line therapy, with guidance for special populations such as patients with poor performance status.

🔗 Read more: bit.ly/ONCOnews04Fe...

#ONCOnews #OncoAlert #OncEd #NSCLC #NonSmallCellLungCancer

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Now Iktos teams up with Pierre Fabre in oncology As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos

#Iktos #PierreFabre #oncology #PierreFabreLaboratories #AIdrugdiscovery #roboticsdrugdiscovery #smallmoleculedrugcandidates #generativeAI #EICAccelerator #PierreFabreMedicalCare #generativeAI #precisiononcology #NSCLC #nonsmallcelllungcancer #solidtumours #rarediseases
zurl.co/Gx2yL

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

#KelunBiotech has picked up another first for its #TROP2 targeting antibody-drug conjugate (#ADC) sacituzumab tirumotecan (sac-TMT), after getting Chinese approval of the drug in #nonsmallcelllungcancer (NSCLC).

pharmaphorum.com/news/kelun-g...

Regeneron's Libtayo stakes out new territory in skin cancer Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

#Regeneron #Libtayo #cemiplimab #skincancer #Squamouscellcarcinoma #checkpointinhibitor #FDA #cutaneoussquamouscellcarcinoma #CSCC #basalcellcarcinoma #nonsmallcelllungcancer #cervicalcancer #highriskCSCC #KEYNOTE630study #CPOSTstudy #Libtayotreatedpatients #PD1PDL1inhibitors
zurl.co/9toKK

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...